心脏瓣膜病遗传学
Genetics of Valvular Heart Disease
DOI: 10.12677/ACM.2018.81004, PDF,  被引量   
作者: 刘 洁:青岛大学,山东 青岛;王仁萍:青岛大学附属医院健康查体中心,山东 青岛
关键词: 心脏瓣膜心脏瓣膜发育遗传学瓣膜性心脏病Heart Valve Heart Valve Development Genetics Valvular Heart Disease
摘要: 心脏瓣膜病伴有显著的发病率和死亡率,并且常是由于先天性畸形引起心脏瓣膜结构和功能异常,导致瓣口狭窄或关闭不全所致的。然而,成年人心脏瓣膜病患病率日益增加,不仅是因为老龄化日益严重,而且还因为先天性心脏瓣膜缺陷儿童的医疗和外科护理的改善。人类基因组计划的成功和遗传技术的重大进展,加上我们对心脏瓣膜发育的了解越来越多,导致人们发现许多心脏瓣膜疾病的遗传因素。这些发现使用各种方法,包括家族性瓣膜病的检查和全基因组关联研究,以调查散发病例。本综述将讨论这些发现及其在瓣膜性心脏病治疗中的意义。
Abstract: Valvular heart disease is associated with significant morbidity and mortality, and is often caused by congenital malformations resulting in abnormal cardiac valve structure and function, resulting in stenosis or insufficiency of the valve. However, the prevalence of valvular heart disease in adults is increasing, not only because of the growing aging, but also because of the improvement of medical and surgical care for children with congenital heart valve defects. The success of genomics project and the great progress of genetic technology, and our increasing understanding of cardiac valve development have led to the discovery of many genetic factors of heart valve disease. These findings use a variety of methods, including familial valvular disease examination and genome wide association studies to investigate sporadic cases. This review will discuss these findings and their significance in the treatment of valvular heart disease.
文章引用:刘洁, 王仁萍. 心脏瓣膜病遗传学[J]. 临床医学进展, 2018, 8(1): 22-27. https://doi.org/10.12677/ACM.2018.81004

参考文献

[1] Sathyamurthy, I. and Alex, S. (2015) Calcific Aortic Valve Disease: Is It Another Face of Atherosclerosis? Indian Heart Journal, 67, 503-506.
[Google Scholar] [CrossRef] [PubMed]
[2] Go, A.S., et al. (2013) Heart Disease and Stroke Statistics—2013 Update: A Report from the American Heart Association. Circulation, 127, e6-e245.
[Google Scholar] [CrossRef
[3] d'Arcy, J.L., et al. (2011) Valvular Heart Disease: The Next Cardiac Epidemic. Heart, 97, 91-93.
[Google Scholar] [CrossRef] [PubMed]
[4] Hoffman, J.I. and Kaplan, S. (2002) The Incidence of Congenital Heart Disease. Journal of the American College of Cardiology, 39, 1890-900.
[Google Scholar] [CrossRef
[5] Maganti, K., et al. (2010) Valvular Heart Disease: Diagnosis and Management. Mayo Clinic Proceedings, 85, 483-500.
[Google Scholar] [CrossRef] [PubMed]
[6] Lincoln, J. and Garg, V. (2014) Etiology of Valvular Heart Dis-ease-Genetic and Developmental Origins. Circulation Journal, 78, 1801-1807.
[Google Scholar] [CrossRef
[7] Combs, M.D. and Yutzey, K.E. (2009) Heart Valve Development: Regulatory Networks in Development and Disease. Circulation Research, 105, 408-421.
[Google Scholar] [CrossRef
[8] Sugi, Y., et al. (2004) Bone Morphogenetic Protein-2 Can Mediate Myocardial Regulation of Atrioventricular Cushion Mesenchymal Cell Formation in Mice. Developmental Biology, 269, 505-518.
[Google Scholar] [CrossRef] [PubMed]
[9] Yutzey, K.E., Colbert, M. and Robbins, J. (2005) Ras-Related Signaling Pathways in Valve Development: Ebb and Flow. Physiology (Bethesda), 20, 390-397.
[Google Scholar] [CrossRef] [PubMed]
[10] Briggs, L.E., et al. (2013) Expression of the BMP Receptor Alk3 in the Second Heart Field Is Essential for Development of the Dorsal Mesenchymal Protrusion and Atrioventricular Septation. Circulation Research, 112, 1420-1432.
[Google Scholar] [CrossRef
[11] Wu, B., et al. (2011) Nfatc1 Coordinates Valve Endo-cardial Cell Lineage Development Required for Heart Valve Formation. Circulation Research, 109, 183-192.
[Google Scholar] [CrossRef
[12] Negoro, H., et al. (2011) Regulation of Connexin 43 by Basic Fibroblast Growth Factor in the Bladder: Transcriptional and Behavioral Implications. Journal of Urology, 185, 2398-2404.
[Google Scholar] [CrossRef] [PubMed]
[13] Garg, V., et al. (2005) Mutations in NOTCH1 Cause Aortic Valve Disease. Nature, 437, 270-274.
[Google Scholar] [CrossRef] [PubMed]
[14] Siu, S.C. and Silversides, C.K. (2010) Bicuspid Aortic Valve Disease. Journal of the American College of Cardiology, 55, 2789-2800.
[Google Scholar] [CrossRef] [PubMed]
[15] Della Corte, A., et al. (2014) Surgical Treatment of Bicuspid Aortic Valve Disease: Knowledge Gaps and Research Perspectives. Journal of Thoracic and Cardiovascular Surgery, 147, 1749-1757.
[16] de la Pompa, J.L. and Epstein, J.A. (2012) Coordinating Tissue Interactions: Notch Signaling in Cardiac Development and Disease. Developmental Cell, 22, 244-254.
[Google Scholar] [CrossRef] [PubMed]
[17] Foffa, I., et al. (2013) Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2genes in Familial Cases of Bicuspid Aortic Valve. BMC Medical Genetics, 14, 44.
[Google Scholar] [CrossRef] [PubMed]
[18] Laforest, B., Andelfinger, G. and Nemer, M. (2011) Loss of Gata5 in Mice Leads to Bicuspid Aortic Valve. Journal of Clinical Investigation, 121, 2876-2887.
[Google Scholar] [CrossRef
[19] Dupuis, L.E., et al. (2013) Insufficient Versican Cleavage and Smad2 Phosphorylation Results in Bicuspid Aortic and Pulmonary Valves. Journal of Molecular and Cellular Cardiology, 60, 50-59.
[Google Scholar] [CrossRef] [PubMed]
[20] Thomas, P.S., et al. (2012) Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid Aortic Valve Development. PLoS One, 7, e35539.
[Google Scholar] [CrossRef] [PubMed]
[21] Freed, L.A., et al. (1999) Prevalence and Clinical Outcome of Mitral-Valve Prolapse. The New England Journal of Medicine, 341, 1-7.
[Google Scholar] [CrossRef
[22] Gupta, V., et al. (2009) Abundance and Location of Pro-teoglycans and Hyaluronan within Normal and Myxomatous Mitral Valves. Cardiovascular Pathology, 18, 191-197.
[Google Scholar] [CrossRef] [PubMed]
[23] Ritelli, M., et al. (2013) Clinical and Molecular Characterization of 40 Patients with Classic Ehlers-Danlos Syndrome: Identification of 18 COL5A1 and 2 COL5A2 Novel Mutations. Orphanet Journal of Rare Diseases, 8, 58.
[Google Scholar] [CrossRef] [PubMed]
[24] Lincoln, J., et al. (2006) ColVa1 and ColXIa1 Are Required for Myocardial Morphogenesis and Heart Valve Development. Developmental Dynamics, 235, 3295-3305.
[Google Scholar] [CrossRef] [PubMed]
[25] Disse, S., et al. (1999) Mapping of a First Locus for Autosomal Domi-nant Myxomatous Mitral-Valve Prolapse to Chromosome 16p11.2-p12.1. The American Journal of Human Genetics, 65, 1242-1251.
[Google Scholar] [CrossRef] [PubMed]
[26] Lardeux, A., et al. (2011) Filamin-A-Related Myxomatous Mitral Valve Dystrophy: Genetic, Echocardiographic and Functional Aspects. Journal of Cardiovascular Translational Research, 4, 748-756.
[Google Scholar] [CrossRef] [PubMed]
[27] Sauls, K., et al. (2012) Developmental Basis for Fila-min-A-Associated Myxomatous Mitral Valve Disease. Cardiovascular Research, 96, 109-119.
[Google Scholar] [CrossRef] [PubMed]
[28] Feng, Y., et al. (2006) Filamin A (FLNA) Is Required for Cell-Cell Contact in Vascular Development and Cardiac Morphogenesis. Proceedings of the National Academy of Sciences of the United States of America, 103, 19836-19841.
[Google Scholar] [CrossRef] [PubMed]
[29] Maragh, S., et al. (2011) Identification of RNA Binding Motif Proteins Essential for Cardiovascular Development. BMC Developmental Biology, 11, 62.
[Google Scholar] [CrossRef
[30] Bettinelli, A.L., et al. (2013) Familial Ebstein Anomaly, Left Ventricular Hypertrabeculation, and Ventricular Septal Defect Associated with a MYH7 Mutation. American Journal of Medical Genetics: Part A, 161, 3187-3190.
[Google Scholar] [CrossRef] [PubMed]